Invesaro

Stocks MVNC Financial statements

Financial statements

Marvion Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Marvion Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2010FY2012FY2012FY2013FY2021FY2021FY2022FY2023FY2024FY2025
Revenue000.311.50.661.543.47
Cost of revenue00.098.690.380.781.94
Gross profit00.212.790.280.761.53
Selling and marketing00.190.784.28
General and administrative1.410.770.7801.332.740.261.381.32
Operating expenses2.170.830.98
Operating income-0-2.12-100.03-0.610.21
Interest expense0.090.190.4700.120.22
Interest income000
Other non-operating income0-0.020-0.120.13
Pre-tax income-0-2.12-10.10.03-0.730.34
Income tax00.01-00.020-0
Net income-0.72-2.41-1.09-1.42-0-2.12-100.01-0.730.35
EBITDA0.05-0.530.44
EPS, basic-0.020.000.000.000.00-0.010.000.000.00
EPS, diluted-0.020.000.000.000.00-0.010.000.000.00
Shares, basic (weighted)1,2181,3501,880148194336
Shares, diluted (weighted)1,2181,3501,880148194336

Balance sheet

FY2010FY2012FY2012FY2013FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents00.020.090.0100.030.10.120.320.76
Short-term investments00.67
Receivables00.07
Inventory01.397.77
Other current assets00.10.010.010.020.02
Total current assets0.020.110.0500.144.550.20.651.26
Property, plant and equipment0.010.040.120.761.742.97
Lease right-of-use assets1.361.241.61
Intangible assets00.140.090.04
Total assets0.280.40.7400.294.823.214.045.84
Accounts payable0.090.060.20.060.120.1
Deferred revenue0
Short-term debt-0.57-0.67
Total current liabilities1.172.1502.416.822.294.825.44
Lease liabilities1.351.251.62
Total liabilities0.821.172.2102.416.828.5110.19.76
Paid-in capital4.954.835.5509.94001.77
Retained earnings-14-16.2-26.2-5.34-6.07-5.73
Other comprehensive income-00-0.010-0-0.01
Shareholders' equity-0.26-0.54-1.75-2.45-0-2.12-5.31-5.31-6.04-3.93
Total equity-0.26-0.54-1.75-2.45-0-2.12-5.31-5.31-6.04-3.93
Total liabilities and equity0.280.40.7400.294.823.214.045.84
Shares outstanding2792352901,8681,8681,943309309363

Cash flow statement

FY2010FY2012FY2012FY2013FY2021FY2021FY2022FY2023FY2024FY2025
Net income-0.72-2.41-1.091.42-0-2.12-100.01-0.730.35
Depreciation and amortization00.020.020.090.23
Stock-based compensation1.120.210.39
Deferred income tax0.170.35
Change in receivables-0.07-0.24-0.17
Change in inventory0-6.38
Change in payables0.1-0.080.1702.120.0615.3
Cash from operations-0.2-0.54-0.46-0-0.1-1.190.22-0.180.44
Cash from investing-0.05-0.03-0.150-0.15-0-1.03-0.5-0.9
Stock issued0.180.570.23
Cash from financing0.280.640.5300.281.260.880.90.9
Exchange rate effect00-0.010
Net change in cash0.020.06-0.08-00.030.070.070.20.44
Interest paid00.050.03000000
Income taxes paid000000

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin50.6%Gross profit / revenue.
Operating margin10.8%Operating income / revenue.
EBITDA margin17.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin11.1%Pre-tax income / revenue.
Net margin10.7%Net income / revenue.
Operating cash flow margin21.9%Cash from operations / revenue.
Effective tax rate3.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)7.6%Net income / average total assets.
D&A / revenue7.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y124.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-32.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y100.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-18.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y44.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y366.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y72.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-43.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-22.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.21xCurrent assets / current liabilities.
Quick ratio0.14x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.14x(Cash + short-term investments) / current liabilities.
Liabilities / assets163.9%Total liabilities / total assets.
Interest coverage2.36xOperating income / interest expense.
Working capital-$3.9MCurrent assets - current liabilities.
Tangible book value-$3.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.71xRevenue / average total assets.
Fixed asset turnover1.36xRevenue / average property, plant and equipment.
Days payables22 days365 x average accounts payable / cost of revenue.

Per share

MetricValueHow it is calculated
EPS, diluted$0.00Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.01Revenue / diluted weighted shares.
Operating cash flow per share$0.00Cash from operations / diluted weighted shares.
Book value per share-$0.01Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.01Tangible book value / shares outstanding.
Cash per share$0.00(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.0MShare price x shares outstanding.
Enterprise value$344.5KMarket cap + total debt - cash - short-term investments.
P/E2.50xMarket cap / net income. Only when net income is positive.
P/S0.27xMarket cap / revenue.
P/OCF1.22xMarket cap / cash from operations, when positive.
EV/Sales0.09xEnterprise value / revenue.
EV/EBIT0.84xEnterprise value / operating income, when both are positive.
EV/EBITDA0.51xEnterprise value / EBITDA, when both are positive.
Earnings yield40.0%Net income / market cap (the inverse of P/E).
What was Marvion Inc.'s revenue in fiscal 2025?

Marvion Inc. reported revenue of $3.5M for fiscal 2025, 124.8% higher than the year before.

Was Marvion Inc. profitable in fiscal 2025?

Yes. Net income was $345.1K, a net margin of 9.9%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Marvion Inc.